| Literature DB >> 27571513 |
Wenting Zhao1, Qin Pang1, Ruixue Xu1, Jianwen Liu1, Shengfa Liu1, Jian Li1, Xin-Zhuan Su1,2.
Abstract
Leucocytozoon parasites infect many species of avian hosts, including domestic chicken, and can inflict heavy economic loss on the poultry industry. Two major species of Leucocytozoon parasites have been reported in China, L. sabrazesi and L. caulleryi, although L. sabrazesi appears to be more widespread than L. caulleryi in southern China. The traditional method for detecting Leucocytozoon infection is microscopic examination of blood smears for the presence of mature gametocytes in circulation, which may miss infections with low parasitemia (gametocytemia) or immature gametocytes. Here we developed a PCR-based method to monitor L. sabrazesi infections at seven sites in four provinces of China after testing two PCR primer pairs based on parasite mitochondrial cytochrome b (cytb) and cytochrome c oxidase III (coxIII) genes. We compared the results of PCR detection with those of microscopic observation. As expected, the PCR assays were more sensitive than microscope examination in detecting L. sabrazesi infection and were able to detect parasite DNA after gametocytes disappeared in the blood stream. Using these methods, we investigated monthly dynamics of L. sabrazesi in chickens from a free-range farm in Xiamen, Fujian province of China, over one year. Our results showed that chickens were infected with L. sabrazesi year-round in southern China. Finally, we tested several compounds for potential treatment of Leucocytozoon infections, including primaquine, ketotifen, clomipramine hydrochloride, desipramine hydrochloride, sulfaquinoxaline, and pyrimethamine. Only primaquine had activity against L. sabrazesi gametocytes. Our results provide important information for controlling parasite transmission in southern China and disease management.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27571513 PMCID: PMC5003344 DOI: 10.1371/journal.pone.0161869
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Primer design and detection of diluted DNA samples from an infected chicken.
A and B, Aligned primer sequences based on genes encoding mitochondrial cytochrome b (cytb, A) and cytochrome oxidase subunit III (coxIII, B) from L. sabrazesi (NCBI accession No. AB299369.1), Leucocytozoon caulleryi (Accession No. AB302215.1), Haemoproteus columbae (NCBI accession No. FJ168562.1), Plasmodium gallinaceum (Accession No. AB250690.1), and chicken (Gallus gallus domesticus, Accession No. KM096864.1). C, Amplifications of diluted DNA from an infected chicken with known gametocytemia. DNA sample from infected chicken (#2HC with parasitemia of 0.02%) blood obtained from Haicang, Fujian province, was diluted in water at ratios of 1:10; 1:50; 1:200; 1:1,000; 1:5,000; 1:20,000; 1:100,000; 1:500,000; 1:2×106; and 1:1×107 and was amplified using Ls-coxIIIF2/R2 and Ls-cytbF1/R1 primers, respectively. PCR products (4 μl each) were separated on a 2% agarose gel. A DNA band could be easily detected at 1:1,000 dilution using Ls-coxIIIF2/R2, and a band at 1:5,000 could be seen using the Ls-cytbF1/R1 primers. “+” indicates un-diluted DNA control. The figure is representative of two replicates with the same results.
Fig 3Detection of Leucocytozoon gametocytes or DNA after drug treatments.
A-C, Curves of gametocytemia from two chickens after treatment (daily doses of 2 mg/kg for 14 days) with primaquine (A), ketotifen (B), or no-treatment controls (C). Each line in the graphs of A-C represents gametocytemia from an infected chicken. D, Agarose gels of PCR products from the Ls-coxIIIF2/R2 primers. #1 and #5 were treated with a dose of 2 mg/kg primaquine daily for 14 days; #3 and #4 were treated with a dose of 2 mg/kg ketotifen daily for 14 days; #6 and #7 were controls without treatment. All the chickens were from the Haicang (HC) farm. DNA sample preparation and PCR amplifications were as described in Materials and Methods.
Comparison of microscopic examination of blood smear and the Ls-coxIIIF2/R2 PCR method in detecting Leucocytozoon sabrazesi infection.
| Date | Sample No. | Gametocytemia (%) | PCR detection | Date | Sample No. | Gametocytemia (%) | PCR detection |
|---|---|---|---|---|---|---|---|
| 11-Dec-12 | ZZ-1#1 | 0.004 | + | 5-Jul-13 | HC-3#4 | 0.001 | + |
| 11-Dec-12 | ZZ-1#2 | 0 | - | 5-Jul-13 | HC-3#5 | 0.0067 | + |
| 11-Dec-12 | ZZ-1#3 | 0.011 | + | 5-Jul-13 | HC-3#6 | 0.0047 | + |
| 11-Dec-12 | ZZ-1#4 | 0 | - | 5-Jul-13 | HC-3#7 | 0.0168 | + |
| 11-Dec-12 | ZZ-1#5 | 0.0003 | + | 29-Mar-13 | FZ-1#1 | 0 | - |
| 11-Dec-12 | ZZ-1#6 | 0 | - | 29-Mar-13 | FZ-1#2 | 0 | + |
| 11-Dec-12 | ZZ-1#7 | <0.0001 | + | 29-Mar-13 | FZ-1#3 | 0 | + |
| 11-Dec-12 | ZZ-1#8 | 0 | - | 29-Mar-13 | FZ-1#4 | 0 | + |
| 11-Dec-12 | ZZ-1#9 | 0.0007 | + | 29-Mar-13 | FZ-1#5 | 0 | - |
| 11-Dec-12 | ZZ-1#10 | <0.0001 | + | 29-Mar-13 | FZ-1#6 | 0 | + |
| 11-Dec-12 | ZZ-1#11 | <0.0001 | + | 29-Mar-13 | FZ-1#7 | 0 | + |
| 11-Dec-12 | ZZ-1#12 | <0.0001 | + | 29-Mar-13 | FZ-1#8 | 0 | + |
| 11-Dec-12 | ZZ-1#13 | 0 | - | 29-Mar-13 | FZ-1#9 | 0 | + |
| 11-Dec-12 | ZZ-1#14 | 0.0003 | + | 29-Mar-13 | FZ-1#10 | 0 | - |
| 11-Dec-12 | ZZ-1#15 | 0.005 | + | 29-Mar-13 | FZ-1#11 | 0 | - |
| 11-Dec-12 | ZZ-1#16 | 0 | - | 9-Feb-13 | GZ#1 | 0.0022 | + |
| 11-Dec-12 | ZZ-1#17 | 0 | - | 9-Feb-13 | GZ#2 | 0 | - |
| 11-Dec-12 | ZZ-1#18 | 0.009 | + | 9-Feb-13 | GZ#3 | 0.0046 | + |
| 11-Dec-12 | ZZ-1#19 | 0.007 | + | 9-Feb-13 | GZ#4 | 0 | + |
| 11-Dec-12 | ZZ-1#20 | 0.009 | + | 9-Feb-13 | GZ#5 | 0.0033 | + |
| 11-Dec-12 | ZZ-1#21 | 0.003 | + | 9-Feb-13 | GZ#6 | 0.0045 | + |
| 11-Dec-12 | ZZ-1#22 | <0.0001 | + | 9-Feb-13 | GZ#7 | 0.0038 | + |
| 11-Dec-12 | ZZ-1#23 | 0 | - | 9-Feb-13 | GZ#8 | 0 | + |
| 11-Dec-12 | ZZ-1#24 | 0.022 | + | 10-Mar-13 | RJ#1 | 0 | - |
| 11-Dec-12 | ZZ-1#25 | <0.0001 | + | 10-Mar-13 | RJ#2 | 0 | - |
| 25-Aug-13 | ZZ-2#1 | 0 | + | 10-Mar-13 | RJ#3 | 0 | - |
| 25-Aug-13 | ZZ-2#2 | 0 | + | 10-Mar-13 | RJ#4 | 0 | - |
| 25-Aug-13 | ZZ-2#6 | 0.018 | + | 10-Mar-13 | RJ#5 | 0 | - |
| 25-Aug-13 | ZZ-2#7 | 0.03 | + | 10-Mar-13 | RJ#6 | 0 | - |
| 25-Aug-13 | ZZ-2#8 | 0.0043 | + | 10-Mar-13 | RJ#7 | 0 | - |
| 25-Aug-13 | ZZ-2#9 | 0.0057 | + | 10-Mar-13 | RJ#8 | 0 | - |
| 25-Aug-13 | ZZ-2#11 | 0.0057 | + | 10-Mar-13 | RJ#9 | 0 | - |
| 25-Aug-13 | ZZ-2#13 | 0 | + | 10-Mar-13 | RJ#10 | 0 | - |
| 25-Aug-13 | ZZ-2#14 | 0.0011 | + | 8-Feb-13 | DZ#1 | 0 | - |
| 25-Aug-13 | ZZ-2#19 | 0.0035 | + | 8-Feb-13 | DZ#2 | 0 | - |
| 23-Mar-13 | HC-1#1 | 0.0184 | + | 8-Feb-13 | DZ#3 | 0 | - |
| 23-Mar-13 | HC-1#2 | 0.0492 | + | 8-Feb-13 | DZ#4 | 0 | - |
| 23-Mar-13 | HC-1#3 | 0.013 | + | 8-Feb-13 | DZ#5 | 0 | - |
| 23-Mar-13 | HC-1#4 | 0.0408 | + | 8-Feb-13 | DZ#6 | 0 | - |
| 23-Mar-13 | HC-1#5 | 0 | + | 8-Feb-13 | DZ#7 | 0 | - |
| 23-Mar-13 | HC-1#6 | 0 | - | 8-Feb-13 | DZ#8 | 0 | - |
| 23-Mar-13 | HC-1#7 | 0.0252 | + | 8-Feb-13 | DZ#9 | 0 | - |
| 23-Mar-13 | HC-1#8 | 0.0108 | + | 8-Feb-13 | DZ#10 | 0 | - |
| 23-Mar-13 | HC-1#9 | 0 | - | 16-Feb-13 | BZ#1 | 0 | - |
| 23-Mar-13 | HC-1#10 | 0.0035 | + | 16-Feb-13 | BZ#2 | 0 | - |
| 23-Mar-13 | HC-1#11 | 0 | - | 16-Feb-13 | BZ#3 | 0 | - |
| 23-Mar-13 | HC-1#12 | 0.0097 | + | 16-Feb-13 | BZ#4 | 0 | - |
| 23-Mar-13 | HC-1#13 | 0.0204 | + | 16-Feb-13 | BZ#5 | 0 | - |
| 5-Jul-13 | HC-3#1 | 0.0343 | + | 16-Feb-13 | BZ#6 | 0 | - |
| 5-Jul-13 | HC-3#2 | 0.0487 | + | 16-Feb-13 | BZ#7 | 0 | - |
| 5-Jul-13 | HC-3#3 | 0.0103 | + | 16-Feb-13 | BZ#8 | 0 | - |
Gametocytemia (%) were obtained after counting a total 10,000 blood cells. “+” indicates detection of a PCR product of expected size; and “-” means no product of expected size was detected. Note: Sampling locations: ZZ, Zhangzhou, Fujian province; HC, Haicang, Xiamen, Fujian province; FZ, Fuzhou, Fujian province; GZ, Ganzhou, Jiangxi province; RJ, Ruijin, Jiangxi province; DZ, Dazhou, Sichuan Province; BZ, Binzhou of Shandong province. Note, some of the gametocytemia counts were reported previously [23].
Monthly surveys of Leucocytozoon infections using microscopy of blood smear and the Ls-coxIIIF2/R2 PCR assay.
| Month | No. birds exam | No. birds infected (by smear) | % positive by smear | No. birds infected (by PCR assay) | % positive by PCR assay |
|---|---|---|---|---|---|
| Oct., 2014 | 34 | 15 | 44.1 | 29 | 85.3 |
| Nov., 2014 | 9 | 0 | 0 | 3 | 33.3 |
| Dec., 2014 | 14 | 3 | 21.4 | 6 | 42.9 |
| Jan., 2015 | 14 | 5 | 35.7 | 8 | 57.1 |
| Mar., 2015 | 21 | 8 | 38.1 | 19 | 90.5 |
| Apr., 2015 | 10 | 4 | 40 | 7 | 70 |
| May., 2015 | 4 | 3 | 75 | 3 | 75 |
| Jun., 2015 | 10 | 8 | 80 | 10 | 100 |
| Jul., 2015 | 14 | 8 | 57.1 | 14 | 100 |
| Aug., 2015 | 6 | 4 | 66.7 | 5 | 83.3 |
| Sep., 2015 | 4 | 1 | 25 | 3 | 75 |
| Sum | 140 | 59 | Ave 43.9 | 107 | Ave 73.9 |
The animals were randomly selected from the farm at time of initial sampling. No sample was collected for February due to school winter break and national holidays.
Weekly or biweekly infections of three chickens from a free-range farm in Xiamen, southern China, detected by blood smear or parasite-specific PCR.
| HC#1 | HC#2 | HC#3 | ||||
|---|---|---|---|---|---|---|
| Date | Gametocytemia (%) | PCR detection | Gametocytemia (%) | PCR detection | Gametocytemia (%) | PCR detection |
| 1-Apr-13 | 1 | + | 0 | + | 0.017 | + |
| 8-Apr-13 | 0.011 | + | <0.001 | + | 0.041 | + |
| 16-Apr-13 | 0.02 | + | 0.007 | + | 0.163 | + |
| 22-Apr-13 | 0.012 | + | 0.008 | + | 0.101 | + |
| 29-Apr-13 | 0.004 | + | 0.027 | + | 0.066 | + |
| 6-May-13 | <0.001 | + | 0 | + | 0.084 | + |
| 12-May-13 | <0.001 | + | 0.002 | + | 0.045 | + |
| 17-May-13 | 0 | + | <0.001 | + | <0.001 | + |
| 21-May-13 | <0.001 | + | <0.001 | + | 0.009 | + |
| 28-May-13 | <0.001 | + | <0.001 | + | 0.057 | + |
| 7-Jun-13 | 0 | + | <0.001 | + | 0.004 | + |
| 17-Jun-13 | 0 | + | 0 | + | 0.012 | + |
| 10-Jul-13 | 0 | + | 0 | + | 0.005 | + |
| 22-Jul-13 | 0 | + | <0.001 | + | 0 | + |
| 5-Aug-13 | 0 | + | 0.001 | + | 0.001 | + |
| 15-Aug-13 | 0 | + | 0 | + | 0 | + |
| 3-Sep-13 | 0 | + | 0 | + | 0 | + |
| 18-Sep-13 | 0 | + | 0 | + | 0 | + |
| 2-Oct-13 | 0 | + | 0 | + | 0 | + |
| 14-Oct-13 | 0 | + | 0 | + | 0 | + |
Note: HC, Infected chickens from Haicang district, Xiamen city, Fujian province.”+”, indicates PCR products of expected size.